Guanfacine to Treat Borderline Personality Disorder
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to investigate whether guanfacine (Tenex) is an effective treatment
for borderline personality disorder (BPD), an illness often characterized by unstable mood
and impulsive aggression. Guanfacine stimulates activity in the front portion of the brain, a
region associated with attention and the control of behavior. We believe that guanfacine may
improve symptoms of BPD by improving attention and aiding regulation of behavior.